Updated CIDG Collection: diagnosing tuberculosis

07 Nov 2022

To mark this year’s The Union Conference (8-11 November 2022), Cochrane Infectious Diseases has released an updated collection on diagnosing tuberculosis, which highlights Cochrane Reviews relevant to this topic.

Tuberculosis continues to cause great suffering worldwide. According to the World Health Organization (WHO), in 2021 an estimated 10.6 million people developed tuberculosis, an increase of 4.5% from 2020. This collection includes selected systematic reviews from Cochrane Infectious Diseases and other international teams that underpin three WHO consolidated guidelines on systematic screening for tuberculosis disease and on rapid diagnostics for detection of tuberculosis and tuberculosis drug resistance. The collection highlights how Cochrane evidence contributes within a wider landscape of tuberculosis evidence and guidelines.

The Special Collection was curated by Mikashmi Kohli, Adrienne Shapiro, and Karen Steingart (Cochrane Infectious Diseases). Nazir Ismail, Alexei Korobitsyn, and Cecily Miller (WHO Global Tuberculosis Programme) contributed to previous versions. 

 

Acknowledgements

This publication is associated with the Research, Evidence and Development Initiative (READ-It) project. READ-It (project number 300342-104) is funded by UK aid from the UK government; however, the views expressed do not necessarily reflect the UK government’s official policies. We are grateful to Christopher Gilpin (Global Laboratory Coordinator, Migration Health Division, International Organization for Migration) for contributing to the initial version of this Special Collection.